House Democrats request information from CDC on hepatitis B study in Guinea-Bissau
The Hill · October 22, 2026Original source ↗

What happened
Members of the House Energy and Commerce Committee requested information from the CDC regarding its funding of a hepatitis B clinical trial in Guinea-Bissau. The CDC provided $1.6 million for this study conducted by Danish researchers.
Why it matters
Understanding the CDC's funding decisions can impact public health policy and resource allocation.
How this story affects people
How does this story affect you if you are a public health advocate?
This inquiry could influence future funding decisions and research priorities, potentially affecting how resources are allocated for disease prevention and treatment initiatives globally. Increased scrutiny may lead to more transparency in how public health studies are funded, impacting advocacy efforts.
How does this story affect you if you are a resident of Guinea-Bissau?
The outcomes of this clinical trial could directly affect your community's health, particularly regarding hepatitis B prevention and treatment options. If the study leads to new insights or interventions, it may improve health outcomes for those affected by the virus.
Read a briefing based on your profile
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Download on the App Store3 free Ripples in total. Read without an account. iPhone · iOS 26.0+ · United States
More stories
- HealthRising NHS waiting times impact child healthcare in England
- HealthCDC implements requirements for international travelers to the US regarding Ebola
- HealthSurvey shows increase in employer health insurance costs for workers
- HealthUnitedHealthcare and Humana to Discontinue Medicare Advantage Plans for 1 Million Members